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Abstract
Background
While the association of ethnic group with individual cardiovascular diseases has been stud-
ied, little is known about ethnic differences in the initial lifetime presentation of clinical cardio-
vascular disease in contemporary populations.
Methods and results
We studied 1,068,318 people, aged 30 years and free from diagnosed CVD at baseline
(90.9% White, 3.6% South Asian and 2.9% Black), using English linked electronic health
records covering primary care, hospital admissions, acute coronary syndrome registry
and mortality registry (CALIBER platform). During 5.7 years median follow-up between
1997–2010, 95,224 people experienced an incident cardiovascular diagnosis. 69.9%
(67.2%-72.4%) of initial presentation in South Asian <60 yrs were coronary heart disease
presentations compared to 47.8% (47.3%-48.3%) in White and 40.1% (36.3%-43.9%) in
Black patients. Compared to White patients, Black patients had significantly lower age-
sex adjusted hazard ratios (HRs) for initial lifetime presentation of all the coronary disease
diagnoses (stable angina HR 0.80 (95% CI 0.68–0.93); unstable angina– 0.75 (0.59–
0.97); myocardial infarction 0.49 (0.40–0.62)) while South Asian patients had significantly
higher HRs (stable angina– 1.67 (1.52–1.84); unstable angina 1.82 (1.56–2.13); myocar-
dial infarction– 1.67 (1.49–1.87). We found no ethnic differences in initial presentation
with heart failure (Black 0.97 (0.79–1.20); S Asian 1.04(0.87–1.26)). Compared to White
patients, Black patients were more likely to present with ischaemic stroke (1.24 (0.97–
1.58)) and intracerebral haemorrhage (1.44 (0.97–2.12)). Presentation with peripheral
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arterial disease was less likely for Black (0.63 (0.50–0.80)) and South Asian patients
(0.70 (0.57–0.86)) compared with White patients.
Discussion
While we found the anticipated substantial predominance of coronary heart disease presen-
tations in South Asian and predominance of stroke presentations in Black patients, we
found no ethnic differences in presentation with heart failure. We consider the public health
and research implications of our findings.
Trial Registration
NCT02176174, www.clinicaltrials.gov
Introduction
Cardiovascular disease accounts for more than a quarter of all deaths in England and Wales[1]
and contributes 15% of all disability adjusted life years lost in England.[2]. However the bur-
den of cardiovascular disease (CVD) in the United Kingdom (UK) varies between ethnic
groups and type of CVD diagnosis.[3] Compared to White UK residents, South Asian resi-
dents have been found to be at increased risk of angina,[4,5] myocardial infarction,[6] coro-
nary heart disease[7,8] but lower risk of heart failure,[9] and out-of-hospital cardiac arrest
[10,11]. In contrast, Black residents have been found to be at increased risk of stroke in most
but not all studies[7,12,13] and similar or lower risk of heart failure[9,14] and other heart dis-
eases compared to White UK residents.[15,7,11] Studies are lacking on ethnic differences in
incidence of some cardiovascular disease diagnoses, specifically peripheral arterial disease,
stroke subtypes, and abdominal aortic aneurysm.
Despite the range of studies investigating ethnic differences in incident cardiovascular dis-
eases, most previous studies have looked at individual or a limited number of cardiovascular
diseases in isolation.[16–24] It is unknown how UK ethnic groups differ in the cardiovascular
disease with which they are first diagnosed across a range of specific acute and chronic disease
diagnoses. First lifetime cardiovascular disease diagnosis is a turning point in a patient’s expe-
rience, marking the end of the possibility of primary prevention and the beginning of the need
to consider secondary prevention, so understanding how these might differ by ethnic group is
important. However, comparisons across such a broad range of outcomes need the large sam-
ple sizes to reliably identify ethnic differences in association.
We have created a large UK-based prospective cohort using linked electronic health re-
cords with detailed information on ethnic group, cardiovascular risk factors and diagnoses in
order to address this gap in knowledge.[25] Specifically, we sought to address the following
objectives:
1. To examine the proportion of the total burden of CVD comprised by specific cardiovascu-
lar diagnoses for White, South Asian and Black patients, the largest ethnic groups in the
UK.
2. To determine how South Asian and Black patients differ from White patients in the initial
lifetime diagnosis of cardiovascular disease, across a broad range of cardiovascular
diagnoses.
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3. To determine whether any associations found are independent of common cardiovascular
risk factors such as age, sex, social deprivation, hypertension and diabetes.
Methods
Data sources
Anonymised patient records were selected from the Clinical disease research using LInked
Bespoke studies and Electronic health Records (CALIBER) programme described[25] and vali-
dated[26–31] elsewhere. In brief, patients for the cohort were drawn from the Clinical Practice
Research Database (CPRD) which also provided data from the primary care medical record.
Patients registered in practices submitting linkable data to CPRD, covering approximately 4%
of the English population, have been found to be representative of the English population in
terms of age, gender and ethnicity.[32,33]
Further data on the cohort patients was drawn from three other linked clinical datasets: the
Myocardial Ischaemia National Audit Project (MINAP) registry, Hospital Episodes Statistics
(HES) and the UK national death registry from the Office for National Statistics (ONS).
Study population
We studied 1,068,318 patients registered between January 1997 and March 2010 from 225 gen-
eral practices across England submitting data to CPRD. We required that at study entry
patients were aged30 years, free of diagnosed CVD and had been followed-up for at least
one year. We did not impose an upper age limit and the older patient in the cohort was 109.
We used the entire medical history available on each patient to confirm they were free of diag-
nosed CVD. The period covered by medical history prior to study entry ranged from 20 years
to the stipulated minimum period of 1 year, which previous research has found to be a suffi-
cient period to ensure accurate assessment of baseline history of prior diagnoses.[34] Women
who were pregnant in the 6 months before study entry were excluded, as were patients with no
ethnicity recorded. (See S1 Fig for study flow diagram.) We used an open cohort design, so
patients entered the study when they met the inclusion criteria. Patients were censored on the
earliest date from among: the date of first CVD diagnosis, date of death from other causes,
date leaving the practice or date of last practice data collection.
Exposure variable–ethnic group
In the United Kingdom, recording of patients’ ethnic group has been mandated in the
National Health Service since 1991. Patients are asked to self-classify, specifying the ethnic
group to which they belong when they access either primary or secondary care.
The completeness of ethnicity data has increased over time, with substantial increases in
HES since 2000[35] and in CPRD since 2006 when recording in primary care was incentivised.
[33] We used information on ethnic group recorded in both CPRD (47%) and HES (53%),
resolving any conflicts between the two data sources using a defined and previously validated
algorithm, which found distribution of ethnic groups similar to the national UK Census.[35]
(See S2 Fig for algorithm and source of ethnicity codes.) Patients were categorised as White,
South Asian, Black, or Other/Mixed ethnic groups; these groups reflect the most prevalent eth-
nic groups in the 2011 Census in England and Wales.[36] The White group included White
British, White European and other White Groups. South Asian included patients from Indian,
Pakistani, Bangladeshi and other Asian ethnic groups, including Asian British. Black included
those belonging to African, Caribbean or other Black groups, including Black British. The
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Other/ Mixed group included those from any mixed ethnic group and other small minority
ethnic groups, including Japanese and Chinese.
Covariates
Baseline cardiovascular risk factors were obtained from CPRD, recorded during primary care
consultations. For body mass index (BMI), systolic blood pressure (SBP), total cholesterol
(TChol) and HDL cholesterol (HDL), the most recent measurement recorded up to one year
before study entry was used as the baseline value. Patients were identified as diabetic if there
was a diagnosis of diabetes at any point in the prior medical record, as defined previously by
Shah et al.[37] Similarly, smoking status was determined using the entire prior record to clas-
sify patients as never-smokers, ex-smokers or current smokers at baseline. Deprivation,
divided into quintiles, was measured using the Index of Multiple Deprivation (IMD)[38], a
neighbourhood deprivation score combining indices of unemployment, crime, income, educa-
tion and other markers of social inequality.
Our treatment variables, also obtained from CPRD, [39] included receipt of a repeat pre-
scription (defined as two or more prescriptions in the year prior to study entry) of statins or
blood pressure lowering medication (thiazide diuretics, beta-blockers, angiotensin converting
enzyme-inhibitors, angiotensin receptor blockers, or calcium-channel blockers) at baseline.
We additionally included use of oral contraceptives or hormone replacement therapy (HRT)
in women. Variable definitions can be found at http://www.caliberresearch.org/portal/.
Outcomes
As described in previous papers,[27,30,31] our primary endpoints were defined as the first
recorded diagnosis of the 12 most common symptomatic manifestations of CVD, irrespective
of underlying disease mechanism, arising from pathology in the head, heart, abdomen or legs.
The first diagnosis could occur in primary care, secondary care or at death. We included the
following CVDs: stable angina, unstable angina, non-fatal myocardial infarction (MI), unher-
alded coronary death (UCD), heart failure, a composite of cardiac arrest, ventricular arrhyth-
mia and sudden cardiac death (SCD), transient ischaemic attack (TIA), ischaemic stroke,
subarachnoid haemorrhage (SAH), intracerebral haemorrhage, abdominal aortic aneurysm
(AAA), peripheral arterial disease (PAD), and other deaths. We combined stroke not other-
wise specified with ischaemic stroke, as previous research has identified the large majority of
strokes are ischaemic.[40] Coronary heart disease not otherwise specified (CHD NOS) was
also studied but kept separate from other coronary diagnoses in the analysis. We classified
events as fatal where a death record exists for the same calendar date. Overview of codes and
data sources used to define cardiovascular endpoints has been published previously.[30]
Statistical analysis
Descriptive statistics were used to compare baseline demographic characteristics, risk factors
and the number of primary care consultations, and prescribed medication in the year prior to
entry by ethnic group. We also analysed the proportion of total CVD that individual cardiovas-
cular diagnoses comprised for each ethnic group, within three broad age bands. Continuous
variables are presented as mean while categorical variables are presented as percentages; 95%
confidence intervals are given for all descriptive variables and hazard ratios, unless otherwise
stated.
In primary analyses, we investigated the association of ethnic group with each CVD out-
come across all patients, using White as the reference group. Hazard ratios (HRs) were based
on disease-specific Cox models with length of follow-up as the timescale, adjusted for age
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(linear and quadratic term), sex, and stratified by primary care practice. The association of eth-
nic group with the range of endpoints was analysed in a competing risk framework, i.e. only
one of the range of diseases can be the initial diagnosis of cardiovascular disease, with other
diagnoses competing to be that first diagnosis. Associations for the mixed/other ethnic group
were estimated but are not presented.
In secondary analyses, we investigated the association of ethnic group after adjustment for
classical CVD risk-factors (deprivation, smoking status, SBP, diabetes, BMI, total cholesterol,
HDL cholesterol), and baseline treatment with blood-pressure lowering medication, statins,
and female hormones. We also examined modification of these associations by baseline age
group and gender.
Missing values in covariates were handled using multiple imputation for all analyses. (See
S1 Appendix for details on our approach to imputation.) The proportional hazards assumption
was tested by plotting the Schoenfield residuals for all endpoints, comparing South Asian and
Black patients to White. The assumption was met for all endpoints for all ethnic groups.
Sensitivity analyses
In sensitivity analyses, associations were examined in complete cases and in analyses where
we restricted endpoints to those recorded in secondary care and mortality data or mortality
data alone. From 1st April 2004, primary care practices began receiving substantial financial
rewards for performance in chronic disease management; [41] from 1st April 2006 they
further received rewards for recording ethnic group. We therefore also compared associations
between ethnic group and initial CVD diagnoses before and after 1st April 2006.
All the analyses were performed with Stata 12 or R 3.0.
Ethics
The study was approved by the Independent Scientific Advisory Committee (ISAC) of the
Medicines and Healthcare Products Regulatory Agency (protocol 12_117) and the MINAP
Academic Group. The study was registered at clinicaltrials.gov (trial registration NCT021
76174).
Results
The study cohort comprised 971,283 White, 38,292 South Asian, 30,896 Black and 27,847
Mixed/Other patients, with 6,023,720, 155,278, 133,577 and 114,735 person years of observa-
tion respectively. The ethnic group distribution of the cohort was broadly similar to the
English population of the same age over the period of the cohort.[36,42] A total of 95,224 car-
diovascular events were recorded, 96.2% in White, 1.9% in South Asian, 0.9% in Black and
1.1% in Mixed/Other patients. All further results are reported for the White, South Asian and
Black patients only.
White patients were followed up for a median of 6.1 years, while follow-up time was notably
shorter for South Asian (2.6 years), and Black patients (3.1 years). (Table 1; see S1 Table for
baseline data by age within ethnic group.) Compared with White patients, South Asian and
Black patients were significantly younger at study entry, and were more likely to live in the
most deprived areas. They were also more likely to be never smokers and to have diabetes and
a statin prescription. South Asian patients were less likely to be hypertensive or have BP-lower-
ing medication prescribed, while Black patients were somewhat more likely to be hypertensive,
had lower baseline SBP and were prescribed BP medication in similar proportion to White
patients. BMI was broadly similar in all three groups.
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We found considerable and significant differences between the three ethnic groups in the
proportion of specific CVDs with which cardiovascular disease was first diagnosed (Fig 1).
Coronary heart disease (CHD) diagnoses (stable and unstable angina, unspecified coronary
heart disease, myocardial infarction and unheralded coronary death) predominated in South
Asians, particularly at younger ages, compared to both White and Black patients. 69.9%
(67.2%-72.4%) of initial CVD diagnoses were CHD in South Asian patients aged less than 60
years compared to 47.8% (47.3%-48.3%) in White and 40.1% (36.3%-43.9%) in Black patients
of the same age. South Asian patients were substantially less likely to die from non-CVD causes
before initial lifetime diagnosis with CVD (12.9% (11.2%-14.9%) than either White (27.8%
(27.4%-28.2%)) or Black patients (29.3% (25.9%-33.0%)) because of this predominance of cor-
onary disease. Compared to White patients, South Asians and Blacks were about 10 years
younger at initial lifetime diagnosis of CVD. Age at initial diagnosis further varied by gender
within ethnicity: White women had their initial lifetime diagnosis 13 years later than Black
women, while White men had their first diagnosis 8 years after South Asian men(Table 2).
Compared with White patients, Black patients had significantly lower age-sex adjusted haz-
ard ratios (HRs) for all the coronary disease diagnoses, while South Asian patients had signifi-
cantly higher HRs (Fig 2). We found no ethnic differences in associations with heart failure
presentations. Ethnic associations with stroke diagnoses were more variable: Compared to
White patients, we found excess hazards for South Asian patients for ischaemic stroke (HR
1.29 (1.03–1.62)) and excess hazards approaching significance for Black patients for both
Table 1. Baseline patient characteristics by ethnic group.
White South Asian Black Other Total
N = 971,283 (90.9%) N = 38,292 (3.6%) N = 30,896 (2.9%) N = 27,847 (2.6%) N = 1,068,318
Observation time in years, median (IQR) 6.1 (2.1–10.2) 2.6 (1.1–6.5) 3.1 (1.2–6.9) 2.7 (1.1–6.6) 5.6 (2.0–10.1)
Women, % 55.5 (55.4–55.6) 53.2 (52.7–53.7) 55.4 (54.9–56.0) 57.8 (57.2–58.4) 55.5 (55.4–55.6)
Age at study entry, years 48.6 (48.6–48.7) 41.3 (41.2–41.5) 41.3 (41.2–41.5) 42.2 (42.0–42.3) 48.0 (48.0–48.0)
Social Deprivation, %
Least Deprived 18.9 (18.9–19.0) 11.3 (11.0–11.6) 4.5 (4.3–4.7) 12.0 (11.6–12.4) 17.7 (17.6–17.8)
Most Deprived 19.7 (19.7–19.8) 29.5 (29.0–29.9) 58.7 (58.1–59.2) 31.0 (30.5–31.6) 21.9 (21.6–22.0)
Consultations in year before study 5.5 (5.5–5.5) 6.2 (6.1–6.2) 5.7 (5.7–5.8) 5.2 (5.1–5.3) 5.5 (5.5–5.6)
Smoking status, %
Current smokers 17.3 (17.2–17.4) 17.3 (17.2–17.4) 12.6 (12.3–13.0) 14.3 (13.9–14.8) 17.0 (16.9–17.1)
Ex-smokers 19.8 (19.7–19.9) 9.4 (9.1–9.7) 9.9 (9.5–10.3) 14.9 (14.4–15.4) 18.9 (18.8–19.0)
Never smokers 62.9 (62.8–63.1) 78.0 (77.5–78.4) 75.8 (75.3–76.4) 67.0 (66.3–67.6) 64.1 (64.0–64.2)
Diabetes mellitus, % 2.5 (2.5–2.6) 6.0 (5.8–6.2) 4.6 (4.3–4.8) 2.9 (2.7–3.1) 2.7 (2.7–2.8)
Hypertensive, % 6.0 (6.0–6.1) 4.2 (4.0–4.4) 6.7 (6.5–7.0) 3.8 (3.6–4.1) 5.9 (5.9–6.0)
SBP, mmHg 130.6 (130.5–130.6) 122.9 (122.7–123.1) 127.1 (126.8–127.3) 122.6 (122.3–122.9) 129.9 (129.8–129.9)
DBP, mmHg 78.6 (78.5–78.6) 76.8 (76.7–77.0) 78.6 (78.5–78.8) 76.2 (76.1–76.4) 78.4 (78.4–78.5)
BMI, kg/m2 26.6 (26.6–26.7) 25.6 (25.5–25.7) 27.8 (27.7–27.9) 25.4 (25.3–25.5) 26.6 (26.6–26.6)
Total cholesterol, mmol/L 5.5 (5.5–5.5) 5.1 (5.0–5.1) 5.0 (5.0–5.1) 5.2 (5.2–5.3) 5.4 (5.4–5.4)
HDL cholesterol, mmol/L 1.4 (1.4–1.4) 1.2 (1.2–1.2) 1.4 (1.4–1.4) 1.4 (1.3–1.4) 1.4 (1.4–1.4)
Statin use, % 2.5 (2.4–2.5) 4.6 (4.4–4.8) 3.0 (2.8–3.2) 3.2 (3.0–3.4) 2.6 (2.5–2.6)
Anti-hypertensive drug use, % 15.7 (15.6–15.8) 12.5 (12.1–12.8) 15.1 (14.7–15.4) 10.5 (10.2–10.9) 15.4 (15.4–15.5)
Oral contraceptives/HRT use, %a 29.2 (29.1–29.3) 19.7 (19.2–20.3) 21.0 (20.4–21.6) 22.2 (21.6–22.9) 28.4 (28.3–28.6)
Unless indicated otherwise, values given are means (95% confidence intervals); BMI indicates body mass index; DBP, diastolic blood pressure; HDL, high
density lipoprotein; SD; standard deviation; SBP, systolic blood pressure; HRT, hormone replacement therapy.
a In women only.
https://doi.org/10.1371/journal.pone.0178945.t001
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ischaemic stroke (1.24 (0.97–1.58)) and intracerebral haemorrhage (1.44 (0.97–2.12)).
There were no significant ethnic differences in associations with subarachnoid haemorrhage,
possibly due to the small number of events. Results for a composite stroke endpoint also
approached significance (Black 1.18 (0.98, 1.44); South Asian 1.07 (0.89, 1.30)). South Asian
patients had significantly lower HRs for PAD and AAA, while Black patients had lower HRs
for PAD only.
Adjustment for cardiovascular risk factors and medications, using multiple imputation to
handle missing data, made little difference to the associations between ethnic group and the
range of initial diagnoses (Fig 3).
Compared to White patients of the same age, the increased hazard of stable angina and
CHD NOS in South Asians aged 30 to 59 was significantly greater, with the excess risk also
raised in patients aged 60–74 but not older (S3 Fig). The hazards of the other cardiovascular
diagnoses were not significantly modified by age group for both South Asian and Black groups,
although the initial diagnosis with heart failure in Black patients compared to White showed a
declining hazard with age. The associations between ethnic group and initial diagnosis of CVD
were generally not modified by sex except for TIA in Black patients (S4 Fig).
Restricting endpoints to those from secondary care and mortality made no material differ-
ence to the associations between ethnic group and specific initial diagnoses of CVD. Similarly
there was little difference in the association of ethnic group with all CVDs (except ischaemic
stroke) prior to and after 2006 when incentivisation for recording of ethnic group began,
despite a marked increase in recording of ethnicity data after this point (S5 Fig). The complete
Fig 1. Differences between ethnic groups in coronary, cardiac, cerebrovascular, abdominal and
peripheral arterial disease diagnoses as a proportion of total incident cardiovascular disease and
deaths from other causes, in three age bands (<60, 60–74, 75+).
https://doi.org/10.1371/journal.pone.0178945.g001
Table 2. Age at cardiovascular disease onset in years.
White South Asian Black Mixed/Other Total
All patients 71.2 (71.1–71.3) 61.5 (60.9–62.0) 62.1 (61.2–62.9) 67.2 (66.5–67.9) 71.0 (70.9–71.0)
Men 68.2 (68.1–68.3) 60.4 (59.7–61.1) 62.8 (61.7–63.9) 64.1 (63.1–65.1) 68.0 (67.9–68.1)
Women 74.2 (74.1–74.3) 62.9 (62.0–63.8) 61.4 (60.3–62.5) 70.2 (69.2–71.3) 73.9 (73.8–74.0)
https://doi.org/10.1371/journal.pone.0178945.t002
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case analysis was underpowered to detect any meaningful association between ethnicity and
the full range of cardiovascular disease endpoints (S6 Fig).
Discussion
In this large population-based cohort of over 1 million patients, with a median of 5.7 observa-
tion years and more than 95,000 events, we found strong evidence of heterogeneity in both
size and direction of associations between ethnic group and 12 different CVD presentations.
We demonstrated overwhelming predominance of CHD diagnoses as the first lifetime expres-
sion of CVD in South Asian patients. In Black patients increased hazards of ischaemic and
haemorrhagic stroke were consistent with previous studies but we could not rule out a null
association.[13,43,44] The associations we found were generally robust to adjustment for car-
diovascular risk factors and medication use.
The predominance of CHD diagnoses in South Asians was particularly strong in the youn-
gest age group (less than 60 years), with 70% of all first lifetime diagnoses being different mani-
festations of coronary disease, compared to 48% in White patients and 40% in Black. South
Asian patients were substantially less likely to die than either White or Black patients from a
non-CVD cause of death than they were to have CHD diagnosed. The striking finding does
suggest that serious consideration should be given to prioritising younger South Asian patients
for cardiovascular risk assessment, through programmes such as the NHS Health Checks
programme.
Fig 2. Association between ethnic group and initial lifetime diagnosis of coronary, cardiac, cerebrovascular, abdominal and peripheral arterial
diseases and deaths from other causes, adjusted* for age and sex. Hazard ratios (HRs) of South Asian and Black patients compared to White
patients; *adjustments included age, quadratic age, sex and stratification by primary care practice.
https://doi.org/10.1371/journal.pone.0178945.g002
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Fig 3. Association between ethnic group and initial lifetime diagnosis of coronary, cardiac, cerebrovascular, abdominal
and peripheral arterial diseases and deaths from other causes, adjusted for age and sex*, CVD risk factors**, and
Ethnicity and the first diagnosis of a wide range of cardiovascular diseases
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Black patients were significantly less likely than White to be diagnosed with one of the coro-
nary heart disease diagnoses as a first CVD diagnosis, which is not consistent with previous
UK EHR studies[5,15] or US studies on ethnic differences.[18,44] Critically, however, our
findings are consistent with those which investigated CHD within a competing risk framework
in both the UK[43] and the US,[24] indicating the importance of taking account of other possi-
ble first CVD diagnoses or deaths from other causes in understanding ethnic differences. Dif-
ferences in access to healthcare, which is free at the point of delivery in the UK but often based
on ability to pay in the US, may also play a role in explaining our findings.[45]
Our finding of no association of incident heart failure with ethnic group differs from previ-
ous findings both in the UK[14] and the US[22,23], though consistent with a large study of
heart failure prevalence with adequate representation of ethnic minority groups.[46] Unlike
the US studies, the Black patients in our study had rates of hypertension comparable to White
patients. Additionally, our focus on initial lifetime presentation within a competing risk frame-
work of a range of CVDs would exclude cases of heart failure which were sequelae of myocar-
dial ischaemia, unlike other studies of incident heart failure, and may also explain differences
to previous studies.
The association with individual stroke types as well as a composite stroke endpoint for
Black patients differs in size but not direction found in previous stroke incidence studies.
[13,43] The size of association we found for Black patients was comparable to a major US
study on ethnicity and CVD endpoints which used a competing risk framework. Unlike that
study, we did not find an increased risk of deaths from non-CVD causes for Black patients
compared to White patients.[12,24,43] Our finding that South Asians had a reduced hazard of
PAD compared to White patients is consistent with existing studies,[19] while the reduced
hazard in Black patients is not.[19,47] The Black patients in our study were significantly less
likely to be current or ex-smokers and had comparable rates of hypertension compared the
White patients, which may explain the lower hazard of PAD.[48]
Adjustment for common CVD risk factors, including diabetes, did not change the associa-
tions we found between ethnic group and our endpoints, which is consistent with a recent
study on ethnic differences for CHD but not stroke or heart failure. [23,49] Previous work on
the association of type 2 diabetes and a range of endpoints using CALIBER data did not find
differences between ethnic groups.[37]
Our results demonstrate the important contribution cohorts constructed from clinically col-
lected electronic health records can provide in the understanding of relative risk of different diseases
between ethnic groups, complementing findings from bespoke investigator-led cohort studies.
Limitations
While one of the strengths of our study is the size of cohort we were able to construct, one lim-
itation of our study is the large number of patients we excluded because their ethnicity was not
recorded (S2 and S3 Tables compare those excluded from the cohort because of unrecorded
ethnicity with the cohort patients.). We cannot exclude possible impact on our results of this
selection bias, although we note our data sources have been found to be representative of the
English population in terms of ethnicity.[33]
medications***. Hazard ratios (HRs) of South Asian and Black patients compared to White patients; *adjustments for age and sex
included age, quadratic age, sex and stratification by primary care practice; adjustments for CVD risk factors further included
deprivation, smoking, diabetes, systolic blood pressure, body mass index, total cholesterol, and HDL cholesterol; ***adjustment for
medications further included statin use, anti-hypertensive drug use and oral contraceptives/HRT use in women only; SCD indicates
sudden cardiac death, NOS, not otherwise specified.
https://doi.org/10.1371/journal.pone.0178945.g003
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Recording of ethnic group in primary care settings increased significantly after incentivisa-
tion payments started in 2006, with a differential increase in recording of South Asian and
Black ethnic groups. (See S6 Fig) While our sensitivity analysis found no difference in the asso-
ciation of ethnic group with our CVD outcomes pre and post incentivisation, the conse-
quences of this increase was the mean observation time for patients from South Asian and
Black groups was approximately half of that for White patients and patients from these groups
were more likely to be censored for administrative reasons (transferred out of the practice or
end of study). It is possible that if these groups were observed for longer, more events and dif-
ferent associations with CVD diagnoses might have been observed. In order to assess the possi-
ble impact of this bias in observation time on our results, we estimated the age-sex adjusted
HRs for all end points when we censored patients at the median observation time for the
South Asian patients—2.3 years in men and 2.9 years in women—if they had not had an initial
diagnosis or been censored for other reasons before then. For this post-hoc sensitivity analysis,
we had a total of 27,982 cardiovascular events, 30% of the events in the uncensored cohort.
While the HRs were slightly attenuated, the relative differences between the ethnic groups
remained unchanged (S7 Fig), which suggests that differences in observation times between
the ethnic groups is not a significant source of bias in our results.
We used relatively broad categories for ethnic group, which may mask differences within
these categories, such as differences between African and Caribbean patients or Pakistani, Ban-
gladeshi and Indian patients, as has been found in other studies [6,13,14,50]. We note that the
HR for our composite South Asian group for incident myocardial infarction is similar to that
found in Scotland for Pakistani patients.[15]
Although a strength of this study is the ability to investigate a wide range of cardiovascular
diseases with significant number of events in the main ethnic groups, a number of potential
risk factors were not recorded in our data sources. We cannot exclude unmeasured confound-
ing due to diet, physical activity, country of birth,[51] experience of racism, ethnic density,[52]
other environmental factors, individual measures of socio-economic status,[53], or other
unknown factors. We were, however, able to include measures of small area deprivation which
has been shown to be associated with coronary heart disease independently of individual
socio-economic status.[54] Additionally, we must recognise the possibility of errors in the
individual EHR data sources [55,56], which could lead to misattribution of different endpoints.
Nonetheless, there is good evidence for the validity of our risk factors and disease endpoints.
First, a recent systematic review of studies validating diagnoses in CPRD found a median posi-
tive predictive value of 88% across a wide range of diagnoses,(7) while a separate systematic
review found the accuracy of discharge coding in HES to be 83%,[56] indicating the general
validity of these data sources for identifying clinical disease. Second, using identical definitions
for these same 12 diseases in a larger cohort, we have replicated anticipated risk factor/ disease
associations with age and gender,[30] systolic and diastolic blood pressure,[27] type 2 diabetes,
[37] smoking,[31] socioeconomic deprivation,[29] depression,[57] and alcohol.[58]
Public health and clinical implications
Our findings suggest that screening for cardiovascular disease should be prioritised in South
Asian patients, especially in the under 60s, compared to other ethnic groups. Currently, the
NHS Health Checks, a national programme screening for vascular disease in patients without
clinical diagnosed disease, does not specifically mandate prioritising South Asians for risk
assessment.[59] Additionally, QRISK2,[60] the only cardiovascular screening tool currently
recommended for use in the UK by the National Institute for Health and Clinical Excellence,
[61] whether for individual patients or to prioritise patients for programmes such as NHS
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Health Checks,[62] has been found to under-predict the risk of CVD in this very population.
[63] QRISK2 also does not include peripheral arterial disease as an endpoint in the risk predic-
tion calculation, which is likely to underestimate CVD risk in White patients, for whom PAD
is a significant initial diagnosis.
Given the substantially younger median age of first disease diagnosis in Black and South
Asian women compared to White, clinicians should be encouraged to be alert to the possibility
of cardiovascular disease in younger women from these minority groups. Further research to
understand better the interplay between age, ethnic group and gender is needed to elucidate
explanations for this difference.
Research implications
The heterogeneity of association between ethnicity and different CVDs highlights the impor-
tance of considering the full range of cardiovascular disease presentations in studies of ethnic-
ity, as well as the role of alternate presentations play in competing risks for individual CVDs.
Better recording of ethnic group in primary care since 2006 will enable further research in this
area with longer follow-up time as additional data years becomes available. Inclusion of better
area measures of ethnic composition and other measures of small neighbourhood character as
potentially mediating factors in the relationship between CVD and ethnicity should be consid-
ered. Mixed ethnic groups have been increasing over time, which may mean that ethnic groups
in the UK are becoming less distinct with time. In the future it may be clinically useful to think
about genotype directly, rather than ethnicity.
We note with interest the number of patients across all ethnic minorities who remain free
of clinical diagnoses of CVD to age 75. Further research to investigate ethnic differences in
those who manage to avoid these common diseases into older age would add to the literature
in this area.[64,65]
Conclusions
Our study reinforces and amplifies the importance of incident coronary heart disease for
South Asians, particularly those under the age of 60, raising the question about whether they
should be prioritised for cardiovascular risk assessment in programmes like NHS Health
Checks. We reassuringly found no difference between ethnic groups in initial presentation
with heart failure and a smaller than anticipated excess relative risk of the stroke presentations
in Black patients. We have also identified the importance of considering the full range of car-
diovascular disease presentations so that opportunities for secondary prevention are not
missed. We also found differences between ethnic groups in the proportions with modifiable
cardiovascular risk factors, specifically higher prevalence of diabetes and hypertension in
Asian and Black groups which could indicate areas for targeting of prevention education for
different ethnic groups.
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